Primary brain lymphomas in patients with a prior or concomitant malignancy

Michele Reni, A. J M Ferreri, Maria C. Zoldan, Eugenio Villa

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

The increased incidence of second malignancies among cancer survivors is well documented. Thus, differential diagnosis between metastatic spread from a prior malignancy and the occurrence of a new neoplasm should be considered. This is particularly difficult for brain lesions due to their poor prognosis that often discourages diagnostic work-up. In some cases diagnosis of a second primary neoplasm, such as primary central nervous system lymphomas (PCNSL), could change the therapeutic management and the prognosis. About 8% of PCNSL occurs as a second malignancy. Homogeneous and intense tomographic enhancement, deep location of lesions and dramatic response to corticosteroids are suggestive for PCNSL and should be carefully considered before the start of treatment for cerebral lesions. Prognosis and standard management of brain metastases and PCNSL are almost completely different. In addition, while treatment of brain metastases often has a palliative purpose the goal in PCNSL treatment is the cure. Four patients with PCNSL as a second malignancy are reported and literature is reviewed. Diagnosis of PCNSL changes the strategy of treatment which could have a critical therapeutic and prognostic impact.

Original languageEnglish
Pages (from-to)135-142
Number of pages8
JournalJournal of Neuro-Oncology
Volume32
Issue number2
DOIs
Publication statusPublished - 1997

Fingerprint

Lymphoma
Central Nervous System
Second Primary Neoplasms
Brain
Neoplasms
Therapeutics
Neoplasm Metastasis
Survivors
Adrenal Cortex Hormones
Differential Diagnosis
Incidence

Keywords

  • Carcinogenesis
  • Extranodal lymphomas
  • Primary central nervous system lymphomas
  • Second tumors

ASJC Scopus subject areas

  • Cancer Research
  • Clinical Neurology
  • Oncology
  • Neuroscience(all)

Cite this

Primary brain lymphomas in patients with a prior or concomitant malignancy. / Reni, Michele; Ferreri, A. J M; Zoldan, Maria C.; Villa, Eugenio.

In: Journal of Neuro-Oncology, Vol. 32, No. 2, 1997, p. 135-142.

Research output: Contribution to journalArticle

@article{147135bfca4540899eb8d3b6a3e88937,
title = "Primary brain lymphomas in patients with a prior or concomitant malignancy",
abstract = "The increased incidence of second malignancies among cancer survivors is well documented. Thus, differential diagnosis between metastatic spread from a prior malignancy and the occurrence of a new neoplasm should be considered. This is particularly difficult for brain lesions due to their poor prognosis that often discourages diagnostic work-up. In some cases diagnosis of a second primary neoplasm, such as primary central nervous system lymphomas (PCNSL), could change the therapeutic management and the prognosis. About 8{\%} of PCNSL occurs as a second malignancy. Homogeneous and intense tomographic enhancement, deep location of lesions and dramatic response to corticosteroids are suggestive for PCNSL and should be carefully considered before the start of treatment for cerebral lesions. Prognosis and standard management of brain metastases and PCNSL are almost completely different. In addition, while treatment of brain metastases often has a palliative purpose the goal in PCNSL treatment is the cure. Four patients with PCNSL as a second malignancy are reported and literature is reviewed. Diagnosis of PCNSL changes the strategy of treatment which could have a critical therapeutic and prognostic impact.",
keywords = "Carcinogenesis, Extranodal lymphomas, Primary central nervous system lymphomas, Second tumors",
author = "Michele Reni and Ferreri, {A. J M} and Zoldan, {Maria C.} and Eugenio Villa",
year = "1997",
doi = "10.1023/A:1005781815202",
language = "English",
volume = "32",
pages = "135--142",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Springer New York LLC",
number = "2",

}

TY - JOUR

T1 - Primary brain lymphomas in patients with a prior or concomitant malignancy

AU - Reni, Michele

AU - Ferreri, A. J M

AU - Zoldan, Maria C.

AU - Villa, Eugenio

PY - 1997

Y1 - 1997

N2 - The increased incidence of second malignancies among cancer survivors is well documented. Thus, differential diagnosis between metastatic spread from a prior malignancy and the occurrence of a new neoplasm should be considered. This is particularly difficult for brain lesions due to their poor prognosis that often discourages diagnostic work-up. In some cases diagnosis of a second primary neoplasm, such as primary central nervous system lymphomas (PCNSL), could change the therapeutic management and the prognosis. About 8% of PCNSL occurs as a second malignancy. Homogeneous and intense tomographic enhancement, deep location of lesions and dramatic response to corticosteroids are suggestive for PCNSL and should be carefully considered before the start of treatment for cerebral lesions. Prognosis and standard management of brain metastases and PCNSL are almost completely different. In addition, while treatment of brain metastases often has a palliative purpose the goal in PCNSL treatment is the cure. Four patients with PCNSL as a second malignancy are reported and literature is reviewed. Diagnosis of PCNSL changes the strategy of treatment which could have a critical therapeutic and prognostic impact.

AB - The increased incidence of second malignancies among cancer survivors is well documented. Thus, differential diagnosis between metastatic spread from a prior malignancy and the occurrence of a new neoplasm should be considered. This is particularly difficult for brain lesions due to their poor prognosis that often discourages diagnostic work-up. In some cases diagnosis of a second primary neoplasm, such as primary central nervous system lymphomas (PCNSL), could change the therapeutic management and the prognosis. About 8% of PCNSL occurs as a second malignancy. Homogeneous and intense tomographic enhancement, deep location of lesions and dramatic response to corticosteroids are suggestive for PCNSL and should be carefully considered before the start of treatment for cerebral lesions. Prognosis and standard management of brain metastases and PCNSL are almost completely different. In addition, while treatment of brain metastases often has a palliative purpose the goal in PCNSL treatment is the cure. Four patients with PCNSL as a second malignancy are reported and literature is reviewed. Diagnosis of PCNSL changes the strategy of treatment which could have a critical therapeutic and prognostic impact.

KW - Carcinogenesis

KW - Extranodal lymphomas

KW - Primary central nervous system lymphomas

KW - Second tumors

UR - http://www.scopus.com/inward/record.url?scp=0031055389&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031055389&partnerID=8YFLogxK

U2 - 10.1023/A:1005781815202

DO - 10.1023/A:1005781815202

M3 - Article

VL - 32

SP - 135

EP - 142

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 2

ER -